Emeis share price sinks below €10.83, −22% over one month
Emeis is experiencing significant selling pressure on Thursday, extending a decline that has already erased more than a quarter of its value over three months. The security is trading well below its three moving averages, in a Paris market itself under strain, as concerns about French public finances weigh on overall sentiment.
A decline of 5.82% that worsens technical deterioration across all timeframes
Emeis falls 5.82% to €10.20 during the session, bringing its weekly loss to 15.35% and its monthly loss to 22.02%. The security is among the steepest declines on the SBF 120, in an index that itself is down 1.25% at midday. The drop places the price far below its moving average references: it stands 15.77% below the 20-day MA at €12.11, 22.73% below the 50-day MA at €13.20, and 26.72% below the 200-day MA at €13.92.
The RSI at 22 signals a pronounced oversold configuration, which had already prevailed during the bounce observed around the €11.78 level in late September without preventing a new downward sequence since. The former support level at €10.83 has been broken during the session, mechanically transforming it into nearby resistance, while the next resistance level is identified at €14.17.
Half-year results beating expectations, but now distant from market concerns
When publishing first-half 2026 results on July 29, the group's management had raised its annual guidance, considering that the trajectory since the beginning of the year had "exceeded initial expectations". This positive fundamental context is insufficient to halt pressure on the security, which is posting a 30.89% decline over one year. The session is unfolding against a backdrop of tensions in French public finances: the yield on the ten-year government bond reached 4.86% on Thursday, an unprecedented level in more than a decade, while the spread with Germany is approaching 1.30 percentage points.
This context of rising rates is weighing on all securities sensitive to healthcare spending and public financing, of which Emeis is part. During the session, the price is testing the €10.20 zone, well below the broken support at €10.83, which directs attention toward longer-term lows for the security.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.